API Market Size Worth USD 239.8 Billion By 2025

January 2017 | Report Format: Electronic (PDF)

The global active pharmaceutical ingredients (API) market is expected to reach a value of USD 239.8 billion by 2025, based on a new report by Grand View Research, Inc. The rising prevalence of lifestyle-induced & age-related diseases and cancer is projected to drive the market over the forecast period. Advancements in recombinant molecular technologies and high capitalization for development of novel drugs are also estimated to boost growth. 

Favorable government initiatives for increasing focus toward generic drugs is a key factor for market growth. Decrease in generic drug prices, higher acceptance in low income and decrease in reimbursement for branded drugs are the recent trends in the market affirming growth of generic drugs. 

 To request a sample copy or view summary of this report, click the link below:

Further Key Findings from the Study Suggest:

  • Synthetic APIs was the largest segment by revenue share in 2015 owing to high demand.

  • Biotech APIs are estimated to grow lucratively over the forecast period with high R&D initiatives being undertaken for their development

  • Captive manufacturers, being the conventional option of API manufacturing, held the majority of the share.

  • On the other hand, the merchant manufacturers segment is expected to be fastest-growing due to growing outsourcing activities

  • Generic APIs will experience lucrative growth over the forecast period attributed to patent expirations of branded drugs

  • APIs are identified to have highest application in cardiovascular therapeutics. Increasing mortality caused by heart diseases and growing demand for fast-acting drugs are the major factors contributing to dominance

  • North America dominated in terms of revenue share in 2015 and Asia Pacific is expected to grow at a significant growth rate over the forecast period

  • Some of the major companies in the API market are AbbVie, Inc., Boehringer Ingelheim GmbH, Cipla, Inc., and Merck & Co., Inc.

Grand View Research has segmented the API market by type of synthesis, type of manufacturer, type, applications, and region:

API Type of Synthesis Outlook (Revenue, USD Billion, 2014 - 2025)

  • Biotech

    • Monoclonal antibodies

    • Recombinant proteins

    • Vaccines

  • Synthetic

API Type of Manufacturer Outlook (Revenue, USD Billion, 2014 - 2025)

  • Captive APIs

  • Merchant APIs

API Type Outlook (Revenue, USD Billion, 2014 - 2025)

  • Generic APIs

  • Innovative APIs

API Application Outlook (Revenue, USD Billion, 2014 - 2025)

  • Cardiovascular Disease

  • Oncology

  • CNS & Neurological Disorders

  • Orthopedic Disorders

  • Endocrinology

  • Pulmonology

  • Gastrointestinal Disorders

  • Nephrology

  • Ophthalmology

API Regional Outlook (Revenue, USD Billion, 2014 - 2025)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

  • Asia Pacific

    • China

    • Japan

  • Latin America

    • Mexico

    • Brazil

  • MEA

    • South Africa

Request Sample
Request for Customization

Choose License Type

Single User - $3,450
Multi User - $4,450
Library Access - $6,950

Buy Chapters or Sections

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Custom research service

    Custom research service

    Speak to the report author to design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service excellence represented in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • BOA